Camp4 Therapeutics Corporation
CAMP
$4.69
-$0.31-6.20%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -56.23% | -46.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -56.23% | -46.89% | |||
| Cost of Revenue | -10.68% | -9.54% | |||
| Gross Profit | 6.45% | 3.22% | |||
| SG&A Expenses | 3.72% | 9.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.93% | -3.94% | |||
| Operating Income | 2.90% | -0.99% | |||
| Income Before Tax | -166.80% | -19.96% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -166.80% | -19.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -166.80% | -19.96% | |||
| EBIT | 2.90% | -0.99% | |||
| EBITDA | 2.65% | -1.14% | |||
| EPS Basic | -35.12% | 11.34% | |||
| Normalized Basic EPS | -39.68% | 14.22% | |||
| EPS Diluted | -35.12% | 11.34% | |||
| Normalized Diluted EPS | -39.68% | 14.22% | |||
| Average Basic Shares Outstanding | 97.47% | 35.29% | |||
| Average Diluted Shares Outstanding | 97.47% | 35.29% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||